(0.81%) 5 058.89 points
(0.75%) 38 187 points
(1.40%) 15 825 points
(-0.01%) $78.99
(5.43%) $2.04
(0.09%) $2 313.10
(0.59%) $26.91
(0.81%) $962.65
(-0.08%) $0.932
(-0.32%) $10.99
(-0.10%) $0.798
(-1.37%) $91.98
-1.69% HKD 5.25
Live Chart Being Loaded With Signals
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China...
Stats | |
---|---|
Tagesvolumen | 3.85M |
Durchschnittsvolumen | 8.99M |
Marktkapitalisierung | 23.74B |
EPS | HKD0 ( 2024-03-25 ) |
Nächstes Ertragsdatum | ( HKD0 ) 2024-05-28 |
Last Dividend | HKD0.0870 ( 2023-06-01 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 10.94 |
ATR14 | HKD0.00700 (0.13%) |
Volumen Korrelation
Shandong Weigao Group Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Shandong Weigao Group Korrelation - Währung/Rohstoff
Shandong Weigao Group Finanzdaten
Annual | 2023 |
Umsatz: | HKD13.23B |
Bruttogewinn: | HKD6.64B (50.21 %) |
EPS: | HKD0.440 |
FY | 2023 |
Umsatz: | HKD13.23B |
Bruttogewinn: | HKD6.64B (50.21 %) |
EPS: | HKD0.440 |
FY | 2022 |
Umsatz: | HKD13.62B |
Bruttogewinn: | HKD7.11B (52.23 %) |
EPS: | HKD0.600 |
FY | 2021 |
Umsatz: | HKD13.15B |
Bruttogewinn: | HKD7.27B (55.27 %) |
EPS: | HKD0.500 |
Financial Reports:
No articles found.
Shandong Weigao Group Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0.0960 (N/A) |
HKD0 (N/A) |
HKD0.0870 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.00175 | 2004-09-02 |
Last Dividend | HKD0.0870 | 2023-06-01 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 39 | -- |
Total Paid Out | HKD1.546 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.64 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.84 | |
Div. Directional Score | 7.51 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
6198.HK | Ex Dividend Knight | 2023-06-08 | Annually | 0 | 0.00% | |
1883.HK | Ex Dividend Knight | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
0912.HK | Ex Dividend Knight | 2023-08-14 | Semi-Annually | 0 | 0.00% | |
0038.HK | Ex Dividend Junior | 2023-06-08 | Sporadic | 0 | 0.00% | |
2798.HK | Ex Dividend Junior | 2023-06-12 | Annually | 0 | 0.00% | |
1458.HK | Ex Dividend Junior | 2023-08-29 | Annually | 0 | 0.00% | |
0536.HK | Ex Dividend Knight | 2023-09-21 | Semi-Annually | 0 | 0.00% | |
6969.HK | Ex Dividend Junior | 2023-09-06 | Semi-Annually | 0 | 0.00% | |
1985.HK | Ex Dividend Knight | 2023-08-18 | Semi-Annually | 0 | 0.00% | |
1061.HK | Ex Dividend Knight | 2023-08-29 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.151 | 1.500 | 6.97 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0595 | 1.200 | 8.02 | 9.62 | [0 - 0.3] |
returnOnEquityTTM | 0.0900 | 1.500 | -0.111 | -0.166 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.46 | 0.800 | 2.71 | 2.17 | [1 - 3] |
quickRatioTTM | 1.753 | 0.800 | 4.39 | 3.51 | [0.8 - 2.5] |
cashRatioTTM | 0.922 | 1.500 | 5.99 | 8.99 | [0.2 - 2] |
debtRatioTTM | 0.124 | -1.500 | 7.94 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 13.95 | 1.000 | 5.94 | 5.94 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.242 | 2.00 | 9.92 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.242 | 2.00 | 9.88 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.186 | -1.500 | 9.26 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.500 | 1.000 | 5.00 | 5.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.165 | 1.000 | 8.70 | 8.70 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.268 | 1.000 | 9.62 | 9.62 | [0.2 - 2] |
assetTurnoverTTM | 0.393 | 0.800 | -0.714 | -0.571 | [0.5 - 2] |
Total Score | 10.18 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.95 | 1.000 | 9.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0900 | 2.50 | -0.0713 | -0.166 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.242 | 2.00 | 9.92 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.51 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.242 | 2.00 | 9.92 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.879 | 1.500 | 7.47 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0844 | 1.000 | -0.389 | 0 | [0.1 - 0.5] |
Total Score | 4.84 |
Shandong Weigao Group
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices. Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.